Bokhari AA, Lai WY, Le AT, Gabre JL, et al. Novel human-derived EML4-ALK fusion cell lines identify ribonucleotide reductase RRM2 as a target of activated ALK in NSCLC. Lung Cancer 2022;171:103-114.
PMID: 35933914